Clarivate is a leading global provider of transformative intelligence, offering enriched data, insights, and analytics to organizations across the scientific research and intellectual property sectors. The company delivers workflow solutions and expert services that empower its clients to navigate the complexities of academia, government, business, and healthcare with greater efficiency and strategic clarity. With a diverse portfolio of products and services, Clarivate spans key areas including Academia & Government, Intellectual Property, Life Sciences, and Healthcare. Its offerings include enriched data sets, advanced analytical tools, and integrated workflow platforms that help clients make informed decisions in areas such as bibliometrics, scientometrics, patent intelligence, and competitive profiling. Clarivate serves a global clientele, supporting institutions and enterprises in their efforts to advance research, manage intellectual assets, and drive innovation. The company’s expertise is particularly valuable in domains such as pharmacy and biotech, patent services, regulatory compliance, trademark protection, and domain and brand security. The company operates through multiple global offices, including principal locations in London, New York, Antwerp, Stockholm, Singapore, Taipei, and Ann Arbor. Its registered office is located at 70 St. Mary Axe, London, EC3A 8BE, United Kingdom, and it is listed on the New York Stock Exchange under the trading symbol CLVT. Clarivate’s mission is to provide transformative intelligence that enables organizations to unlock the full potential of their data and insights. By combining deep domain expertise with cutting-edge technology, the company helps clients achieve breakthroughs in research, innovation, and strategic planning. Through its comprehensive suite of services—including IP Management Software, Patent Services, Patent Intelligence, Brand IP Solutions, and Litigation Intelligence—Clarivate supports every stage of the drug and device lifecycle, ensuring that its clients remain at the forefront of scientific and technological advancement.